Is IL-6 the Right Target in COVID-19 Severe Pneumonia?

Am J Respir Crit Care Med. 2021 Jan 1;203(1):139-140. doi: 10.1164/rccm.202007-2924LE.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19*
  • Humans
  • Interleukin-6*
  • SARS-CoV-2
  • Severity of Illness Index

Substances

  • Antibodies, Monoclonal, Humanized
  • Interleukin-6